NewLink shareholders back Lumos merger

Mar. 18, 2020 8:16 AM ETNewLink Genetics Corporation (NLNK)LUMOBy: Douglas W. House, SA News Editor2 Comments
  • NewLink Genetics (NASDAQ:NLNK) shareholders have voted overwhelmingly in favor of its previously announced merger with Lumos Pharma.
  • The combined company will do business as Lumos Pharma with shares trading on Nasdaq under the ticker "LUMO."
  • Prior to the closing of the tie-up, expected in the coming days, NewLink will execute a 1:9 reverse split of its common stock.

Recommended For You

Comments (2)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.